Nektar Therapeutics (NKTR)
70.97
-1.11
(-1.54%)
USD |
NASDAQ |
Mar 26, 16:00
71.50
+0.53
(+0.75%)
After-Hours: 16:59
Nektar Therapeutics Free Cash Flow : -208.68M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp. | 3.658B |
| Eli Lilly & Co. | 5.964B |
| Rigel Pharmaceuticals, Inc. | 75.66M |
| Esperion Therapeutics, Inc. | -13.09M |
| Insmed, Inc. | -997.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -64.96M |
| Cash from Investing (Quarterly) | 0.372M |
| Cash from Financing (Quarterly) | 38.67M |
| Free Cash Flow Per Share (Quarterly) | -3.201 |
| Free Cash Flow to Equity (Quarterly) | -46.81M |
| Free Cash Flow to Firm (Quarterly) | -55.20M |
| Free Cash Flow Yield | -4.45% |